Geographically, demand for hemorrhagic stroke treatment devices is highest in healthcare systems with well-organized stroke networks and sufficient specialized hospitals to provide neurointerventional care around the clock. North America and parts of Europe benefit from established triage protocols and substantial hospital investment in advanced procedures, while Asia-Pacific has a large patient population and is rapidly expanding high-level hospital capabilities in major urban centers. The underlying clinical need remains a key driver: according to the U.S. Centers for Disease Control and Prevention (CDC, 2023–2024 updates), stroke affects hundreds of thousands of people annually in the United States, sustaining consistent demand for aneurysm-repair tools and other neurovascular devices in capable hospitals. Globally, the burden remains substantial: according to the World Health Organization (WHO, 2022–2024 updates), stroke continues to rank among the leading causes of death worldwide, maintaining long-term pressure on emergency care systems and the devices used to manage high-acuity hemorrhagic events.
Hemorrhagic Stroke Treatment Devices Market, By Device Type (Aneurysm Coiling Devices, Flow Diverters, Aneurysm Clips, Stent-Assisted Coiling Systems, and Aspiration & Thrombectomy Systems), By Stroke Type, By Procedure Type, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4766
|
Published Date
February 2026
|
Pages
327
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Hemorrhagic Stroke Treatment Devices Market size was valued at US$ 1,084.23 Million in 2024, expanding at a CAGR of 7.12% from 2025 to 2032.
The hemorrhagic stroke treatment devices market focuses on medical technologies designed to manage bleeding-type strokes, primarily intracerebral hemorrhage and subarachnoid hemorrhage, including cases caused by ruptured brain aneurysms. These events are medical emergencies, and the choice of treatment devices can significantly influence how quickly bleeding is controlled, the prevention of re-bleeding, and long-term patient outcomes. The market encompasses endovascular devices—such as coils, flow diverters, and stent-assisted systems—that seal aneurysms from within the blood vessel, as well as surgical tools like aneurysm clips used in open procedures when necessary.
Market demand is driven by aging populations, high prevalence of hypertension and other vascular risk factors, and the expansion of hospitals equipped with neurointerventional capabilities. According to the World Health Organization (WHO), stroke is the second leading cause of death globally, responsible for over 6.5 million deaths in 2022, with hemorrhagic strokes accounting for approximately 13% of all stroke cases. Additionally, OECD health data shows that hospital admissions for stroke in OECD countries exceeded 2.5 million annually in 2022, highlighting the scale of treatment need and the associated demand for specialized devices. Purchasing decisions are typically guided by clinical outcomes, safety and complication rates, ease of use in complex anatomies, compatibility with existing hospital systems, and overall cost per treated case, making device performance and supporting clinical evidence critical factors in vendor competition.
Hemorrhagic Stroke Treatment Devices Market- Market Dynamics
Rising Stroke Incidence and Expanded Stroke Center Access Driving Hemorrhagic Treatment Device Adoption
A key driver of the hemorrhagic stroke treatment devices market is the persistent stroke burden combined with the steady expansion of organized stroke care, which increases the number of patients reaching hospitals capable of performing aneurysm repair and other neurovascular interventions. Stroke remains a major public health concern in the United States: according to the U.S. Centers for Disease Control and Prevention (CDC, 2023–2024 updates), hundreds of thousands of people experience a stroke each year, and it continues to rank among the leading causes of long-term disability, motivating hospitals to strengthen acute stroke pathways and improve clinical outcomes. Globally, stroke-related mortality remains high; according to World Health Organization (WHO, 2022–2024 updates), stroke is consistently among the top causes of death worldwide, with aging populations and persistent hypertension contributing to ongoing risk. System-level improvements also play a critical role, as the routing of patients and the concentration of care influence procedure volumes at capable centers. U.S. federal and state public health reporting (2020–2024), including HRSA-supported stroke program data, shows that more regions have implemented enhanced triage and destination protocols, directing severe stroke cases to higher-level facilities where endovascular and surgical device use is most common. For hospitals and neurointerventional teams, this trend directly supports demand for coils, flow diverters, stents, and aneurysm clips, which can help reduce re-bleeding, improve procedural safety, and shorten ICU and overall hospital stays.
Hemorrhagic Stroke Treatment Devices Market- Segmentation Analysis:
The management of hemorrhagic stroke is increasingly shifting toward catheter-based, endovascular treatment pathways, particularly for aneurysm-related bleeding. These minimally invasive procedures can be performed more quickly in specialized centers and often reduce the need for open surgery, lowering patient risk and shortening recovery times. According to the U.S. Centers for Disease Control and Prevention (CDC, stroke information updated 2023–2024), stroke affects hundreds of thousands of Americans each year, maintaining a consistently high volume of acute cases that require neurovascular interventions. This high prevalence drives steady hospital demand for advanced devices, including coils, stents, and flow-diversion systems, that allow clinicians to manage complex aneurysms efficiently while minimizing complications.
Access to specialized stroke care continues to improve through formalized routing and care networks. State health department stroke-system plans and EMS destination protocols updated between 2020 and 2024 indicate that more regions have implemented structured triage rules, directing severe stroke patients to high-capability stroke centers. This ensures that a greater number of hemorrhagic stroke cases are evaluated for endovascular repair, increasing the need for devices capable of navigating challenging vascular anatomy, simplifying procedural steps, and reducing risks that can prolong ICU stays. Government-led initiatives to streamline acute stroke care have directly supported hospitals in optimizing workflow, ensuring faster diagnosis, and facilitating timely intervention.
Clinical considerations also vary depending on whether bleeding occurs within the brain tissue (intracerebral hemorrhage) or around the brain (subarachnoid hemorrhage), influencing device selection and urgency of treatment. The broader global disease burden remains significant: the World Health Organization (WHO, updates 2022–2024) reports that stroke continues to rank among the leading causes of death worldwide, with long-term drivers such as hypertension, diabetes, and aging populations maintaining a high-risk environment. In the U.S., hospitals operate under quality and reporting requirements overseen by the Centers for Medicare & Medicaid Services (CMS, inpatient and quality program updates 2020–2024), which reinforce standardized acute-care protocols. These mandates incentivize investment in stroke-team readiness and procedure-capable device platforms that improve treatment speed, consistency, and patient outcomes. For hospital committees and neurointerventional teams, these trends translate into growing demand for device systems that enhance procedural efficiency, reduce the risk of re-bleeding, and minimize complications, supporting both clinical effectiveness and operational performance in high-acuity stroke care environments.
Hemorrhagic Stroke Treatment Devices Market- Geographical Insights
United States Hemorrhagic Stroke Treatment Devices Market- Country Insights
The United States is a strong market for hemorrhagic stroke treatment devices due to its scale, robust reimbursement environment, and a large network of hospitals equipped to maintain stroke readiness and adopt advanced endovascular technologies. The high stroke burden continues to drive procedure volumes: according to the CDC (2023–2024 updates), stroke remains a leading cause of serious disability, affecting hundreds of thousands of Americans each year, which motivates hospitals to invest in faster diagnosis and intervention capabilities. Hospital incentives and workflow standards also shape procurement patterns: according to the U.S. Centers for Medicare & Medicaid Services (CMS) inpatient payment and quality-program updates from 2020–2024, hospitals operate under ongoing reporting and performance requirements that reinforce standardized acute stroke pathways, supporting the purchase of endovascular device inventories and surgical tools needed for hemorrhagic stroke care.
Hemorrhagic Stroke Treatment Devices Market- Competitive Landscape:
The competitive landscape for hemorrhagic stroke treatment devices is dominated by companies with extensive neurovascular portfolios and strong clinical support, as success depends on robust clinical evidence, physician training, and reliable device performance in complex vascular anatomy. Medtronic plc and Stryker Corporation are widely recognized for their broad neurovascular product lines and strong presence in major stroke centers, supporting hospital standardization and contracting. Terumo Corporation and MicroVention, Inc. are typically associated with catheters and coil systems designed for precise deployment in challenging vessels. Penumbra, Inc. is often linked to aspiration and procedure-support systems used in neurointerventional settings where speed is critical. Boston Scientific Corporation, Abbott Laboratories, and Johnson & Johnson Services, Inc. are seen as large-scale competitors with extensive distribution networks and clinical infrastructure, enabling adoption across broader hospital networks. Across all these vendors, competitive advantage generally stems from device deliverability, complication management, physician training programs, and post-market clinical evidence—factors that hospital committees prioritize when selecting hemorrhagic stroke treatment platforms.
Recent Developments:
- November 2024: AIIMS Delhi and a consortium of 16 Indian hospitals launched the GRASSROOT clinical trial to evaluate Gravity Medical Technology’s stent-retriever for mechanical thrombectomy in patients with large vessel occlusion stroke. The program targets India’s high stroke burden of approximately 1.7 million cases annually, including an estimated 375,000 patients eligible for interventional treatment, while addressing the 2023 gap where only 4,500–5,000 patients received thrombectomy. The trial aims to reduce device pricing to roughly one-quarter of current levels.
- May 2024: IIIT Bangalore, through the Centre for the Internet of Ethical Things, unveiled XoRehab, an IoT-enabled rehabilitation wheelchair designed to support post-hospital physiotherapy for stroke patients. The system uses surface EMG tracking and a 9-degree-of-freedom assistive suit for upper and lower limb movement, with a hospital purchase price of approximately 85,000–90,000 and a rental model to improve patient access.
- September 2021: Hyperfine, Inc. reported results from a Yale New Haven Hospital study of its FDA-cleared portable MRI system, Swoop, for hemorrhagic stroke detection. The system achieved 96.6% specificity for blood-negative cases and 80.4% sensitivity for intracerebral hemorrhage detection across 144 exams, with later software versions reaching 90.5% overall accuracy and 85.3% sensitivity. The bedside design helps reduce ICU patient transport risks and enables faster stroke assessment where conventional CT/MRI access is limited.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- B. Braun SE
- Balt USA, LLC
- Boston Scientific Corporation
- Cook Medical LLC
- Integer Holdings Corporation
- Johnson & Johnson Services, Inc.
- Kaneka Corporation
- Medtronic plc
- Merit Medical Systems, Inc.
- MicroVention, Inc.
- Natus Medical Incorporated
- Nihon Kohden Corporation
- Penumbra, Inc.
- Phenox GmbH
- Rapid Medical Ltd.
- Stryker Corporation
- Terumo Corporation
- W. L. Gore & Associates, Inc.
- Wallaby Medical Holding, Inc.
- Others
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032
- Aneurysm Coiling Devices
- Flow Diverters
- Aneurysm Clips
- Stent-Assisted Coiling Systems
- Aspiration & Thrombectomy Systems
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY STROKE TYPE- MARKET ANALYSIS, 2019 - 2032
- Intracerebral Hemorrhage (ICH)
- Subarachnoid Hemorrhage (SAH)
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2019 - 2032
- Endovascular Procedures
- Surgical Procedures
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Hemorrhagic Stroke Treatment Devices Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Hemorrhagic Stroke Treatment Devices Market Snippet by Device Type
2.1.2. Hemorrhagic Stroke Treatment Devices Market Snippet by Stroke Type
2.1.3. Hemorrhagic Stroke Treatment Devices Market Snippet by Procedure Type
2.1.4. Hemorrhagic Stroke Treatment Devices Market Snippet by End User
2.1.5. Hemorrhagic Stroke Treatment Devices Market Snippet by Country
2.1.6. Hemorrhagic Stroke Treatment Devices Market Snippet by Region
2.2. Competitive Insights
3. Hemorrhagic Stroke Treatment Devices Key Market Trends
3.1. Hemorrhagic Stroke Treatment Devices Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Hemorrhagic Stroke Treatment Devices Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Hemorrhagic Stroke Treatment Devices Market Opportunities
3.4. Hemorrhagic Stroke Treatment Devices Market Future Trends
4. Hemorrhagic Stroke Treatment Devices Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Hemorrhagic Stroke Treatment Devices Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Hemorrhagic Stroke Treatment Devices Market Landscape
6.1. Hemorrhagic Stroke Treatment Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Hemorrhagic Stroke Treatment Devices Market – By Device Type
7.1. Overview
7.1.1. Segment Share Analysis, By Device Type, 2024 & 2032 (%)
7.1.2. Aneurysm Coiling Devices
7.1.3. Flow Diverters
7.1.4. Aneurysm Clips
7.1.5. Stent-Assisted Coiling Systems
7.1.6. Aspiration & Thrombectomy Systems
8. Hemorrhagic Stroke Treatment Devices Market – By Stroke Type
8.1. Overview
8.1.1. Segment Share Analysis, By Stroke Type, 2024 & 2032 (%)
8.1.2. Intracerebral Hemorrhage (ICH)
8.1.3. Subarachnoid Hemorrhage (SAH)
9. Hemorrhagic Stroke Treatment Devices Market – By Procedure Type
9.1. Overview
9.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
9.1.2. Endovascular Procedures
9.1.3. Surgical Procedures
10. Hemorrhagic Stroke Treatment Devices Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Stroke Type, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Specialty Clinics
10.1.4. Ambulatory Surgical Centers
11. Hemorrhagic Stroke Treatment Devices Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Hemorrhagic Stroke Treatment Devices Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Abbott Laboratories
12.2.2. B. Braun SE
12.2.3. Balt USA, LLC
12.2.4. Boston Scientific Corporation
12.2.5. Cook Medical LLC
12.2.6. Integer Holdings Corporation
12.2.7. Johnson & Johnson Services, Inc.
12.2.8. Kaneka Corporation
12.2.9. Medtronic plc
12.2.10. Merit Medical Systems, Inc.
12.2.11. MicroVention, Inc.
12.2.12. Natus Medical Incorporated
12.2.13. Nihon Kohden Corporation
12.2.14. Penumbra, Inc.
12.2.15. Phenox GmbH
12.2.16. Rapid Medical Ltd.
12.2.17. Stryker Corporation
12.2.18. Terumo Corporation
12.2.19. W. L. Gore & Associates, Inc.
12.2.20. Wallaby Medical Holding, Inc.
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- B. Braun SE
- Balt USA, LLC
- Boston Scientific Corporation
- Cook Medical LLC
- Integer Holdings Corporation
- Johnson & Johnson Services, Inc.
- Kaneka Corporation
- Medtronic plc
- Merit Medical Systems, Inc.
- MicroVention, Inc.
- Natus Medical Incorporated
- Nihon Kohden Corporation
- Penumbra, Inc.
- Phenox GmbH
- Rapid Medical Ltd.
- Stryker Corporation
- Terumo Corporation
- W. L. Gore & Associates, Inc.
- Wallaby Medical Holding, Inc.
- Others
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032
- Aneurysm Coiling Devices
- Flow Diverters
- Aneurysm Clips
- Stent-Assisted Coiling Systems
- Aspiration & Thrombectomy Systems
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY STROKE TYPE- MARKET ANALYSIS, 2019 - 2032
- Intracerebral Hemorrhage (ICH)
- Subarachnoid Hemorrhage (SAH)
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2019 - 2032
- Endovascular Procedures
- Surgical Procedures
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
